Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pro-B cell | 5 studies | 72% ± 14% |
Insufficient scRNA-seq data for expression of DNTT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 89% | 9.61 | 579 / 653 | 18% | 126.22 | 109 / 605 |
| spleen | 66% | 4.09 | 159 / 241 | 0% | 0 | 0 / 0 |
| kidney | 47% | 2.00 | 42 / 89 | 10% | 0.72 | 90 / 901 |
| peripheral blood | 52% | 36.33 | 484 / 929 | 0% | 0 | 0 / 0 |
| brain | 40% | 1.75 | 1062 / 2642 | 0% | 0 | 0 / 705 |
| bladder | 29% | 0.76 | 6 / 21 | 1% | 0.04 | 3 / 504 |
| lung | 22% | 0.88 | 130 / 578 | 1% | 0.08 | 9 / 1155 |
| intestine | 15% | 0.46 | 145 / 966 | 0% | 0.00 | 1 / 527 |
| prostate | 12% | 0.49 | 30 / 245 | 0% | 0 | 0 / 502 |
| stomach | 11% | 0.26 | 38 / 359 | 1% | 0.02 | 4 / 286 |
| liver | 10% | 0.24 | 22 / 226 | 2% | 0.04 | 9 / 406 |
| pancreas | 11% | 0.30 | 37 / 328 | 1% | 0.01 | 1 / 178 |
| uterus | 8% | 0.18 | 14 / 170 | 1% | 0.14 | 5 / 459 |
| muscle | 9% | 0.25 | 73 / 803 | 0% | 0 | 0 / 0 |
| heart | 8% | 0.22 | 73 / 861 | 0% | 0 | 0 / 0 |
| esophagus | 7% | 0.22 | 108 / 1445 | 1% | 0.01 | 1 / 183 |
| blood vessel | 7% | 0.18 | 91 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 5% | 0.11 | 13 / 258 | 1% | 0.02 | 3 / 230 |
| breast | 6% | 0.18 | 27 / 459 | 0% | 0.00 | 2 / 1118 |
| ovary | 6% | 0.13 | 10 / 180 | 0% | 0 | 0 / 430 |
| adipose | 5% | 0.15 | 66 / 1204 | 0% | 0 | 0 / 0 |
| skin | 4% | 0.11 | 71 / 1809 | 1% | 0.03 | 6 / 472 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0071897 | Biological process | DNA biosynthetic process |
| GO_0006303 | Biological process | double-strand break repair via nonhomologous end joining |
| GO_0006259 | Biological process | DNA metabolic process |
| GO_0006304 | Biological process | DNA modification |
| GO_0033198 | Biological process | response to ATP |
| GO_0016363 | Cellular component | nuclear matrix |
| GO_0000791 | Cellular component | euchromatin |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0003912 | Molecular function | DNA nucleotidylexotransferase activity |
| GO_0003887 | Molecular function | DNA-directed DNA polymerase activity |
| GO_0003677 | Molecular function | DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | DNTT |
| Protein name | DNA nucleotidylexotransferase (EC 2.7.7.31) (Terminal addition enzyme) (Terminal deoxynucleotidyltransferase) (Terminal transferase) Deoxynucleotidyltransferase |
| Synonyms | TDT |
| Description | FUNCTION: Template-independent DNA polymerase which catalyzes the random addition of deoxynucleoside 5'-triphosphate to the 3'-end of a DNA initiator. One of the in vivo functions of this enzyme is the addition of nucleotides at the junction (N region) of rearranged Ig heavy chain and T-cell receptor gene segments during the maturation of B- and T-cells. . |
| Accessions | Q14182 P04053 ENST00000630152.1 [P04053-2] ENST00000371174.5 [P04053-1] |